OFIX
Orthofix Medical Inc.
OFIX lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
OFIX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Weak |
OFIX's revenue and profitability are currently stable, but its cash flow and balance sheet are under pressure.
OFIX PE Valuation
OFIX has no meaningful PE right now: it lost money over the past year.
OFIX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect OFIX's losses to shrink, with revenue holding steady.
OFIX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.11 | +$1.93 |
| Q2 2026 | -$1.53 | +$1.65 |
| Q1 2026 | -$1.50 | +$2.20 |
| Q4 2025 | -$2.33 | +$0.97 |
| Q3 2025 | -$3.04 | +$0.07 |
| Q2 2025 | -$3.18 | -$0.01 |
| Q1 2025 | -$3.70 | -$0.34 |
| Q4 2024 | -$3.30 | +$0.82 |
OFIX is still losing money, but far less than before: $1.11 per share over the past year, against $4.12 at its worst in late 2023.
OFIX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $207.9M | +1.1% |
| Q2 2026 | $210.9M | +3.8% |
| Q1 2026 | $196.7M | +1.6% |
| Q4 2025 | $219.9M | +2% |
| Q3 2025 | $205.6M | +4.6% |
| Q2 2025 | $203.1M | +2.3% |
| Q1 2025 | $193.6M | +2.7% |
| Q4 2024 | $215.7M | +7.6% |
OFIX's revenue has grown year over year for 15 quarters in a row: $208M last quarter, up 1.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.7% | +9 points |
| Q2 2026 | -3.9% | +4 points |
| Q1 2026 | -7.3% | +18 points |
| Q4 2025 | 0.2% | +5.5 points |
| Q3 2025 | -8.3% | +1.3 points |
| Q2 2025 | -7.9% | +4.7 points |
| Q1 2025 | -25% | -9.7 points |
| Q4 2024 | -5.3% | +3.8 points |
OFIX's operating margin was 0.7% last quarter, up 9 points from the same quarter a year ago.
OFIX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$14.1M | -666% |
| Q2 2026 | -$18.9M | -517% |
| Q1 2026 | -$28.3M | -$3.1M |
| Q4 2025 | $16.8M | +20% |
| Q3 2025 | $2.5M | -61% |
| Q2 2025 | $4.5M | +$4.9M |
| Q1 2025 | -$25.1M | +$4M |
| Q4 2024 | $14.1M | +$35.3M |
OFIX's free cash flow was −$44M over the past year, against −$4M the year before.
OFIX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +272K shares |
| 1 year | +3.6% | +1.4M shares |
| 3 years | +108% | +21.4M shares |
OFIX has 41M diluted shares, up 3.6% from a year ago.
OFIX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.2x | High |
| Q2 2026 | 8.6x | High |
| Q1 2026 | 10.8x | High |
| Q4 2022 | -3.2x | Net Cash |
| Q3 2022 | -3.0x | Net Cash |
| Q2 2022 | -2.6x | Net Cash |
| Q1 2022 | -3.4x | Net Cash |
| Q4 2021 | -4.1x | Net Cash |
OFIX's net debt is about 4.2 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
OFIX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.9 | Oversold |
| Stochastic | 8.4 | Oversold |
OFIX's weekly RSI is 30 (oversold) and its Stochastic is 8 (oversold).
OFIX PE vs Healthcare Sector
| Metric | OFIX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
OFIX has no meaningful PE right now: it lost money over the past year.
OFIX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.85 | 22% below |
| 20 week MA | $9.71 | 29% below |
| 50 week MA | $11.4 | 39% below |
| 100 week MA | $13.0 | 47% below |
| 200 week MA | $14.5 | 52% below |
OFIX is in a downtrend: it's below all five of its weekly moving averages, and 52% below its 200-week average.
OFIX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.0 | $42.6 | -7.5% |
| 2021 | $42.6 | $31.5 | -26% |
| 2022 | $31.5 | $19.3 | -39% |
| 2023 | $19.3 | $13.5 | -30% |
| 2024 | $13.5 | $17.5 | +30% |
| 2025 | $17.5 | $15.2 | -13% |
| 2026 YTD | $15.2 | $6.94 | -54% |
OFIX has finished lower in five of the last six years. It's down 54% so far in 2026.